REGULUS THERAPEUTICS INC - COM NEW (RGLS)

CUSIP: 75915K200

Q4 2019 13F Holders as of 31 Dec 2019

Type / Class
Equity / COM NEW
Total 13F shares
7,152,864
Share change
-554,140
Total reported value
$6,367,148
Price per share
$0.89
Number of holders
19
Value change
-$308,402
Number of buys
3
Number of sells
8

Quarterly Holders Quick Answers

What is CUSIP 75915K200?
CUSIP 75915K200 identifies RGLS - REGULUS THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of REGULUS THERAPEUTICS INC - COM NEW (RGLS) as of Q4 2019

As of 31 Dec 2019, REGULUS THERAPEUTICS INC - COM NEW (RGLS) was held by 19 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 7,152,864 shares. The largest 10 holders included NEA Management Company, LLC, BVF INC/IL, Sarissa Capital Management LP, RENAISSANCE TECHNOLOGIES LLC, CVI Holdings, LLC, Rockefeller Capital Management L.P., GEODE CAPITAL MANAGEMENT, LLC, BlackRock Inc., VANGUARD GROUP INC, and WEDBUSH SECURITIES INC. This page lists 19 institutional shareholders reporting positions in this security for the Q4 2019 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.